Immunogenicity & Safety Study of 15-Valent Pneumococcal Conjugate Vaccine

See also
Status	Clinical Trial	Phase
Completed	`NCT05799976` - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure	N/A
Completed	`NCT05526716` - A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 When Administered Concomitantly With Influenza Vaccine in Adults 50 Years of Age or Older (V116-005, STRIDE-5)	Phase 3
Completed	`NCT02116998` - Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. Pneumoniae	Phase 2
Completed	`NCT00744263` - Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults	Phase 4
Completed	`NCT04559204` - Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4	Phase 4
Active, not recruiting	`NCT04923035` - Paediatric Pneumococcal Pneumonia in Malaysia Prior to and During Pneumococcal Conjugate Vaccine (PCV) Implementation
Completed	`NCT02961231` - Evaluation of PCV Schedules in a Naive Population in Vietnam	Phase 4
Completed	`NCT03460730` - Dynamics of the Immune Response in Children to the 23-valent Pneumococcal Capsular Polysaccharide Vaccine (Pneumovax)	Phase 1
Recruiting	`NCT06136832` - Pneumonia Vaccine Education Intervention Study	N/A
Active, not recruiting	`NCT05079152` - Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4	Phase 4
Completed	`NCT04790851` - Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4	Phase 4
Terminated	`NCT03058211` - Myocardial Injury and Severe Pneumococcal Pneumonia
Recruiting	`NCT04108845` - Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in Healthy Volunteers Aged Above 2 Months	Phase 1
Completed	`NCT03197376` - Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy Infants	Phase 3
Recruiting	`NCT05412030` - A Phase 2 Study to Evaluate the Safety, Tolerability, and Immunogenicity of AFX3772 Vaccine in Healthy Infants	Phase 2
Completed	`NCT03950856` - Lot-to-Lot Consistency of V114 in Healthy Adults (V114-020)	Phase 3
Completed	`NCT04464291` - An Epidemiological Survey to Establish the Spectrum of Circulating Serotypes of S. Pneumoniae, in Patients Older 18 Years	N/A
Completed	`NCT03896477` - Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy Infants	Phase 3
Completed	`NCT05420961` - A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)	Phase 3
Completed	`NCT04278248` - Immunogenicity and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Healthy Volunteers Aged 2 Years and Above	Phase 3

NCT number	NCT04357522
Study type	Interventional
Source	Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Contact
Status	Not yet recruiting
Phase	Phase 3
Start date	July 2020
Completion date	March 2026

Immunogenicity and Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in 2-month-old and 3-month-old Healthy Volunteers

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms